Embryonic stem cell (ESC) pluripotency requires bivalent epigenetic modifications of key developmental genes regulated by various transcription factors and chromatin-modifying enzymes. How these factors coordinate with one another to maintain the bivalent chromatin state so that ESCs can undergo rapid self-renewal while retaining pluripotency is poorly understood. We report that Utf1, a target of Oct4 and Sox2, is a bivalent chromatin component that buffers poised states of bivalent genes. By limiting PRC2 loading and histone 3 lysine-27 trimethylation, Utf1 sets proper activation thresholds for bivalent genes. It also promotes nuclear tagging of messenger RNAs (mRNAs) transcribed from insufficiently silenced bivalent genes for cytoplasmic degradation through mRNA decapping. These opposing functions of Utf1 promote coordinated differentiation. The mRNA degradation function also ensures rapid cell proliferation by blocking the Myc-Arf feedback control. Thus, Utf1 couples the core pluripotency factors with Myc and PRC2 networks to promote the pluripotency and proliferation of ESCs.
INTRODUCTION
Embryonic stem cells (ESCs) undergo rapid self-renewal and can differentiate into any cell type. These features depend on transcription factors including Oct4, Sox2, and Nanog (Boyer et al., 2005; Chen et al., 2008; Kim et al., 2008; Loh et al., 2006) that form the core pluripotency network (Orkin and Hochedlinger, 2011) . This ESC-specific network interacts with both the Myc-based transcription network and a network of chromatinmodifying complexes including the polycomb-repressive complex 2 (PRC2). Together these three networks occupy and regulate a large number of target genes essential for the selfrenewal and differentiation of ESCs Hu et al., 2009; Kim et al., 2010; Ku et al., 2008; Lee et al., 2006) . Although a few factors have been shown to coordinate some aspects of these networks in ESCs (Orkin and Hochedlinger, 2011) , how all three networks are functionally integrated is unknown.
The Myc-centered network promotes proliferation while regulating lineage-specific differentiation (Lin et al., 2009; Smith et al., 2010; Varlakhanova et al., 2010) . However, Myc also activates the Arf tumor suppressor encoded by Cdkn2a (also called Ink4a-Arf), which in turn inhibits cell proliferation. In somatic cells, this feedback mechanism prevents uncontrolled cell proliferation, and its inactivation by mutations leads to tumorigenesis (Cleveland and Sherr, 2004; Eischen et al., 1999) . Whereas cancer cells evade the Myc-Arf feedback loop through mutations, how ESCs block this feedback to allow rapid proliferation is unknown. Oct4, Sox2, and Nanog are required for ESCs to maintain a low level of Arf messenger RNA (mRNA) (Banito et al., 2009; Kawamura et al., 2009; Li et al., 2009; Utikal et al., 2009) . As these transcription factors do not directly bind to Cdkn2a, it is unclear how the pluripotency core antagonizes the Myc-Arf feedback loop to ensure rapid ESC self-renewal.
Besides specific transcriptional regulation, two unique chromatin features contribute to the establishment and maintenance of ESC pluripotency. A less compacted chromatin structure compared to differentiated cells endows ESCs with highly dynamic chromatin organization (Meshorer and Misteli, 2006) . Another chromatin feature of ESCs is the so-called poised bivalent state of developmentally regulated genes that harbor both transcriptionally active (histone 3-lysine 4 trimethylation, H3K4me3) and transcriptionally repressive (histone 3-lysine 27 trimethylation, H3K27me3) epigenetic marks (Bernstein et al., 2006) , which are catalyzed by SET/MLL complexes and PRC2, respectively (Ang et al., 2011; Boyer et al., 2006; Jiang et al., 2011; Landeira et al., 2010; Li et al., 2010; Peng et al., 2009; Shen et al., 2009; Pasini et al., 2010) . These chromatin features lead to a global transcriptional activity so that even repressed developmentally regulated genes are expressed sporadically (Efroni et al., 2008) . Given that these mRNAs neither accumulate to high levels nor translate into large amounts of proteins in ESCs, active mechanisms must exist to prevent their accumulation and translation. Understanding these mechanisms should shed light on these unique properties of ESCs.
The PRC2-catalyzed H3K27me3 is essential for maintaining both the silenced and poised states of bivalent genes. PRC2 recognizes both CpG islands and chromatin features within the GC-rich regions where most bivalent genes reside (Zhou et al., 2011) . However, because both CpG-island densities and chromatin contexts of bivalent genes vary widely, additional regulatory mechanisms are likely required to ensure that appropriate amounts of PRC2 are loaded onto individual bivalent genes in ESCs so that they are neither overly nor insufficiently silenced. Indeed, recent studies of Jarid2, a component of PRC2, have revealed complicated mechanisms of promoting PRC2 loading and activities on bivalent genes. In addition to promoting PRC2 loading, ESCs may actively limit PRC2 binding via a presently unknown mechanism so that the bivalent genes are not overly silenced. The function of PRC2 on bivalent genes must also be coordinated with the core pluripotency factors. As no physical interaction between the core factors and PRC2 has been detected, the core factors may be coupled to PRC2 through their downstream effector(s) in ESCs.
The undifferentiated embryonic cell transcription factor 1 (Utf1) is one of the direct downstream target genes of Oct4 and Sox2, and it is highly expressed in mouse and human ESCs (Nishimoto et al., 2005; Okuda et al., 1998; Tan et al., 2007) . The highest amount of Utf1 is found in the inner cell mass of mouse blastocysts. After implantation, Utf1 expression is silenced in most cells with the exception of some embryonic tissues . In ESCs, Utf1 is only found in the nucleus where it tightly associates with chromatin, and during ESC differentiation, Utf1 is rapidly downregulated. Although Utf1 has been implicated in regulating ESC proliferation and differentiation, the mechanism remains unclear (Nishimoto et al., 2005; van den Boom et al., 2007) . We report here that Utf1 is a component of the bivalent chromatin that regulates gene expression in a context-dependent manner, which connects the pluripotency core to both Myc and PRC2 networks to ensure rapid proliferation and coordinated differentiation of ESCs.
RESULTS

Utf1 Binds to Bivalent Genes to Regulate Their Expression
We expressed biotin-Utf1 at less than 5% of the endogenous Utf1 level ( Figure S1A available online), and we used biotin-mediated and crosslinked ChIP-sequencing (biotin-ChIP-seq) to map Utf1-binding sites in ESCs (Kim et al., , 2010 Shen et al., 2009) . We identified 75,029 chromatin regions with significant Utf1 enrichments (false discovery rate [FDR] < 0.001). Utf1 binding was enriched in gene-rich regions with highest binding near the transcription start sites (TSS) of genes containing dense CpG islands ( Figures 1A-1C and S1B). Gene ontology (GO) analyses revealed a striking enrichment of Utf1 on genes with functions in organ/system development and cell differentiation ( Figure S1C and Table S1 ).
PRC2-ChIP-seq using an antibody to Suz12 (a subunit of PRC2) revealed that Utf1 binding strongly correlated with PRC2 binding (r = 0.71; Figures 1B-1D and S1B). Our Suz12-ChIPseq data set was consistent with previously published data sets (r = 0.82) (Ku et al., 2008) . Of the total 16,380 Utf1-bound genes, $6,116 were bivalent genes (Table S2) , and they exhibited significantly stronger Utf1 enrichment within 5 kb up-and downstream of the TSS than those nonbivalent genes ( Figure 1C ). Utf1 binding was highly correlated (r = 0.6) with H3K27me3 catalyzed by PRC2 but poorly correlated with H3K4me3 (r = 0.21) present on both bivalent promoters and promoters of strongly expressed genes (Figures 1B, S1B, and S1D). Utf1 binding was not correlated with H3K9me3 (r = À0.17) found on heterochromatin ( Figure S1E ). Using different motif-find methods (Bailey and Elkan, 1994; Zheng et al., 2011) , we predicted two similar AG-rich motifs recognized by Utf1 within CpG islands ( Figure 1E ) closely resembling one of the two motifs previously predicted to bind to Jarid2 in PRC2 (Peng et al., 2009 Figure S1I ). Using RNA-seq, we found that 792 genes exhibited changes of expression by at least 1.5-fold (p < 10
Importantly, Utf1 directly bound to 86.6% of the down-and 90.3% of the upregulated genes (Figures 1F and 1G; Tables S3 and S4) . The majority of these are bivalent genes. Thus Utf1 could regulate either repression or activation of bivalent genes in ESCs.
Utf1 Limits Bivalent Gene Silencing by Preventing Excessive PRC2 Binding and H3K27me3
Because Utf1 is strongly enriched on bivalent genes ( Figures 1B  and 1C ), we focused our study on the bivalent genes. We first studied whether Utf1 could limit gene silencing by preventing excessive PRC2 binding and H3K27me3 on bivalent genes because Utf1 and PRC2 were predicted to bind to similar DNA sequences ( Figure 1E ). (Mikkelsen et al., 2007) , and H3K4me3 in ESCs. ChIP-seq enrichment (identified in this study) for Utf1, Suz12, and H3K4me3 was calculated as the ratio of normalized tag counts of the ChIP-seq and the input sequence in a 1 kb window that slides every 200 bp along 10 kb promoter regions. The heatmap is rank-ordered based on the enrichment of Utf1 (blue, enriched; white, not enriched). (C) Utf1 tag density on bivalent genes is higher than on the nonbivalent genes. The normalized Utf1-tag densities, determined as the averaged ratio of normalized tag counts of Utf1-ChIP-seq and the input sample in the 200 bp window, are plotted within the 5 kb up-and downstream of TSS.
RNA interference (RNAi) to reduce the PRC2 subunit Jarid2 (Figure S2D ) and performed biotin-Utf1-ChIP-qPCR on selected bivalent genes. This resulted in an increased binding of Utf1 to the bivalent genes (graph in Figure S2D ). Second, we reexpressed Utf1 in Utf1 À/D ESCs ( Figure S2E ) and carried out Suz12-ChIP-qPCR on selected bivalent genes. After re-expressing Utf1, the increase of Suz12 binding to the bivalent genes in Utf1 À/D ESCs was reduced to levels similar to those seen in Utf1 +/f ESCs (graph in Figure S2E ). Third, we performed electrophoretic mobility shift assay (EMSA) to show that Utf1 and PRC2 competitively bound to the DNA oligo containing the predicted binding motifs for Utf1 and PRC2 ( Figure S2F ). Finally, sequential ChIP-qPCR analyses on selected bivalent genes showed that Utf1 and PRC2 co-occupied the same bivalent genes in wildtype ESCs ( Figure S2G ). Thus, Utf1 prevents oversilencing of bivalent genes by limiting PRC2 binding.
Utf1 Recruits the mRNA-Decapping Protein Dcp1a to Bivalent Genes
To understand how Utf1 could also repress gene expression, we used mass spectrometry (MS) to identify Utf1-interacting proteins. Among the proteins identified by two rounds of MS with a high peptide coverage (Table S5) , we did not find either ATF2 or any subunit of TFIID that was shown to interact with Utf1 in somatic cells Okuda et al., 1998) . However, we identified components of the mRNA-decapping complex, Dcp1a, Ddx6, and Edc3, as candidate Utf1-interacting proteins in ESCs (Ling et al., 2011; Tritschler et al., 2009) . By pulling down biotin-Utf1 expressed in ESCs, we showed that whereas Dcp1a, Ddx6, and Edc3 coimmunoprecipitated with Utf1, the RNA polymerase II (Pol II) and Taf1, two abundant nuclear proteins, were not detectable in the immunoprecipitate ( Figure 3A) . Consistent with the absence of the catalytic subunit Dcp2 (cleaves the 5 0 -methyl cap of mRNAs) in the MS analyses (Table S5) , Dcp2 was not detected in Utf1 immunoprecipitates ( Figure 3A ). We found that Dcp1a, Ddx6, and Edc3 were present in ESC nuclear extracts, whereas Dcp2 was only found in the whole-cell lysate ( Figure 3B ). Similarly, immunofluorescence staining revealed that whereas Dcp1a, Ddx6, and Edc3 were present in both the nucleus and the cytoplasm, Dcp2 was only found in the cytoplasm of ESCs ( Figure 3C ). Thus Utf1 binds to three noncatalytic subunits of the mRNA-decapping complex in the ESC nucleus.
A clear reduction of bright Dcp1a + granules in both the nucleus and the cytoplasm was seen in ESCs upon Utf1 loss and was not due to the reduction of the decapping proteins ( Figures 3D-3F ). Instead, as formation of mRNP-processing granules requires efficient loading of proteins like Dcp1a onto mRNAs, the reduction of Dcp1a + granules in Utf1 À/D ESCs suggests that Utf1
facilitates the recruitment of the noncatalytic subunits of the mRNA-decapping complex to bivalent promoters so they can be loaded onto newly transcribed mRNAs in the nucleus. Indeed, sequential ChIP-qPCR of randomly selected bivalent genes showed that Dcp1a and Utf1 co-occupied these genes (Figure 3G) . Importantly, the binding of Dcp1a to bivalent genes decreased significantly upon Utf1 loss, which was rescued by reintroducing Utf1 into these ESCs ( Figure 3H ). Given that the reduction of Dcp1a binding in the absence of Utf1 is incomplete, additional factors may mediate Dcp1a recruiting.
Utf1 Promotes the Binding of Dcp1a to mRNA in the Nucleus for Cytoplasmic Degradation RNA-seq showed that reduction of Dcp1a by two different short hairpin RNAs (shRNAs) in ESCs resulted in upregulation of many Utf1-bound bivalent genes, including Arf and Hoxa1, without affecting the expression of Nanog, Oct4, Sox2, Utf1, and Suz12 ( Figure 4A and Table S6 ). To show that Utf1 tags the mRNA from leaky bivalent promoters for cytoplasmic degradation by recruiting Dcp1a, we focused on the bivalent gene Arf because it exhibited a low level of expression in Utf1
ESCs, which was further upregulated in Utf1 and Utf1 À/D ESCs ( Figure 4B ), which was consistent with a role of Myc in activating Arf transcription in ESCs. Finally, S1 nuclease protection assays showed that Arf mRNA was properly spliced in the nucleus of Utf1 +/f ESCs ( Figure S3E ). Thus, Utf1 does not regulate Arf transcription or splicing in the nucleus.
We then performed RNA immunoprecipitation (RIP) with Dcp1a antibody and nuclear extracts made from Utf1 À/D and Utf1 +/f ESCs. qPCR analyses showed that the binding of Dcp1a to Arf mRNA was significantly reduced upon Utf1 loss ( Figure 4D ). Next, we used flavopiridol to inhibit Pol II (Rahl et al., 2010) and northern blotting to probe for Arf mRNA levels. We found that Utf1 À/D ESCs were less efficient in degrading Arf mRNA compared to Utf1 +/f ESCs ( Figure 4E ). Thus, Utf1 recruits Dcp1a to bivalent promoters, which facilitates the loading of Dcp1a to mRNAs transcribed from leaky bivalent genes for cytoplasmic degradation.
Utf1 Buffers Bivalent Gene Expression in a Context-Dependent Manner
The above findings reveal that whereas Utf1 limits PRC2 binding to prevent excessive H3K27me3 and bivalent gene silencing, it also recruits Dcp1a to bivalent genes to repress gene expression through mRNA pruning ( Figure 5A ). These dual functions could allow Utf1 to enforce the poised state of bivalent genes residing See also Figure S1 and Tables S1, S2 , S3, and S4. Figure S2 and Table S2 . island densities and weaker PRC2 binding than the downregulated genes ( Figures 5B-5D ). Importantly the upregulated genes exhibited less PRC2 binding increase upon Utf1 loss than the downregulated genes ( Figures 5B, 5E , and 5F). These analyses suggest the following modes of context-dependent bivalent gene regulation by Utf1. For bivalent genes that have low CpG island densities and PRC2 binding or are bound by strong transcriptional activators (see Arf as an example), Utf1 would repress gene expression because the loss of mRNA pruning due to Utf1 loss could not be compensated for by the limited gaining of PRC2 ( Figure 5G ). By contrast, for bivalent genes with high CpG island densities and strong PRC2 binding, Utf1 would prevent gene silencing because upon Utf1 deletion, the loss of mRNA pruning would be overcompensated by the excessive gaining of PRC2 ( Figure 5H ).
We have shown that Utf1 uses Dcp1a to repress genes such as Hoxa1 and Arf ( Figure 4A ; Tables S4 and S6), which is consistent with the model in Figure 5G . Because our studies suggest that Utf1 recruits Dcp1a to bivalent genes, we analyzed how the loss of Dcp1a could affect the expression of genes that use Utf1 to limit their repression (see Figure 5H ). As these genes exhibit stronger PRC2 binding than the other bivalent genes, Dcp1a loss may or may not affect their expression depending on the strength of PRC2-mediated gene repression. Indeed, we found that 56% (164/295) of them did not show gene expression change upon Dcp1a loss, suggesting that PRC2 was sufficient for their repression. We did find that 41% (121 out of 295) of bivalent genes in this group underwent upregulation upon Dcp1a reduction, suggesting that they depended on both Figure S3 and Table S6. PRC2 and Dcp1a for repression. The above analyses predict that whereas Utf1 functions in ESCs to maintain rapid cell proliferation by repressing Arf expression through Dcp1a-mediated mRNA pruning, both the mRNA pruning and the epigenetic functions of Utf1 also ensure proper gene expression during ESC differentiation. Figure S4D ). Inhibiting Arf expression using shRNA ( Figure 6D ) resulted in a significant increase of cell proliferation rates in Utf1 À/D ESCs without affecting the rate of Utf1 +/f ESCs (Figure 6C) . Thus upregulation of Arf upon Utf1 deletion was ESCs is consistent with our finding that Arf is only one of the targets of Utf1 in ESCs. The p53-p21 Cip1 pathway represents the best characterized mechanism by which Arf inhibits cell-cycle progression (Pomerantz et al., 1998; Zindy et al., 1998) . The binding of Arf to Mdm2, an ubiquitin ligase for p53, leads to Mdm2 inhibition and p53 accumulation. The increase in p53 could lead to transcriptional upregulation of the cell-cycle inhibitor p21
Utf1 Antagonizes Myc-Mediated Activation of Arf to Ensure Rapid Proliferation of ESCs
Cip1
, which would slow down cell-cycle progression. We found that although Arf upregulation led to a small increase of p53 levels in Utf1
Cip1 was not upregulated (Figures 6A and 6F Figures 2A, 2E , and 2F). Hoxa1 was upregulated either upon Utf1 loss or upon Dcp1 RNAi (see Figure 4A ; Tables S4 and  S6 ), suggesting that the mRNA-pruning mechanism is important for controlling Hoxa1 expression. We used embryoid body (EB)-based differentiation and qPCR assays and found that whereas Olig2, Nestin, and T were insufficiently upregulated, Hoxa1 underwent excessive upregulation during EB differentiation of Utf1 À/D ESCs compared to Utf1 +/f ESCs ( Figure 7A ). Additional qPCR analyses of other bivalent genes expressed in mesoendoderm (Gata6 and Bmp4) or during epithelium-tomesenchyme transition (EMT, Cd44) revealed a similar misregulation ( Figure 7A ).
To study how Utf1 could affect gene expression and lineagespecific differentiation, we used ZHBTc4 ESCs, in which the endogenous Oct4 was replaced by a tetracyclin (Tc)-regulated Oct4 transgene (Niwa et al., 2000) . ZHBTc4 ESCs undergo efficient trophectoderm (TE) differentiation in the presence of Tc. The upregulation of the transcription factor Cdx2 during TE development in vivo is required for establishing progenitor cells for TE . In vitro, Cdx2 is not essential for terminal TE differentiation from ESCs, but it is required for the establishment and maintenance of trophoblast stem (TS) cells that undergo further terminal differentiation into TE lineages . Upon Utf1 loss, the Cdx2 gene locus exhibited a significant increase of PRC2 binding and H3K27me3 in ESCs (see Figures 2E and 2F) , predicting that Cdx2 would not be sufficiently upregulated when Utf1-knockdown ESCs were induced to differentiate toward TE. Consistently, we found that addition of Tc to ZHBTc4 ESCs treated with Utf1 shRNA led to insufficient Cdx2 upregulation ( Figure 7B ) and rapid terminal differentiation as judged by the formation of large and flat terminally differentiated TE cells, whereas the control shRNAtreated ZHBTc4 ESCs formed many colonies made of small TS-like cells upon Tc and FGF4 treatment ( Figures 7C and 7D) . Thus although Utf1 deletion did not block the differentiation of ESCs to TE, it disrupted proper coupling between proliferation and differentiation.
DISCUSSION
Using a combination of genomic, cell biology, proteomic, and gene-targeting approaches, we uncover a mechanism that integrates the pluripotency core factors with the PRC2-based epigenetic network and Myc regulation. This mechanism has three features. First, the core factors use their direct downstream target Utf1, which itself is a chromatin-associated protein enriched at bivalent genes, to control both self-renewal and proper differentiation. Second, the core factors use Utf1 to block the Myc-Arf feedback loop to ensure rapid cell proliferation. An important function of the core factors in reprogramming is to block the expression of Arf and Ink4a. However, because none of the core factors directly binds to Cdkn2a, the mechanism of repression has remained unknown. Our findings provide the critical missing molecular link that allows ESCs to evade the Myc-Arf feedback control. Third, Utf1 integrates all three networks using both epigenetic regulation and a previously unappreciated mRNA pruning mechanism ( Figure 7E) .
The differential PRC2 loading on bivalent genes invites the question of how the genes with high or low PRC2 binding are neither oversilenced nor derepressed, respectively. We show that Utf1 and PRC2 bind to bivalent genes competitively because they recognize similar AG-rich motifs, which allows Utf1 to prevent excessive loading of PRC2 in ESCs. How Utf1 or PRC2 binds to chromatin is unclear. Interestingly, H2AZ is one of the Utf1-interacting proteins identified in our MS analyses. Because H2AZ binds to PRC2-bound genes (Creyghton et al., 2008) , studying the functional relationship between H2AZ and Utf1 may help to understand how Utf1 is loaded onto bivalent genes. We note that our biotin-Utf1-ChIP-seq data are not Error bars, SD of triplicates. Student's t test in (C) and (H), *p < 0.05, **p < 0.01. See also Figure S4 .
consistent with the native-ChIP-on-chip studies of Utf1 (Kooistra et al., 2010) . The native-ChIP procedure involved micrococcal nuclease treatments and additional manipulations for extended time without cross-linking, which could fail to capture the true Utf1-chromatin interactions. Our data suggest that by binding to Dcp1a, Ddx6, and Edc3, Utf1 ensures that mRNAs transcribed from leaky bivalent genes are tagged for efficient degradation by the mRNA-decapping pathway. The mRNA-decapping complex, which has only been studied in fungi and in animal somatic cells, promotes the formation of mRNP-processing granules that either prevent mRNA translation or facilitate mRNA degradation (Ling et al., 2011; Tritschler et al., 2009 ). Our findings have revealed a previously unappreciated function of the mRNA-decapping complex in silencing bivalent genes that are insufficiently repressed in ESCs. As a component of the mRNA-decapping complex, Dcp1a could promote both the binding of mRNA to Dcp2 and the decapping activity of Dcp2 to facilitate mRNA degradation in the ESC cytoplasm. Dcp1a could also promote mRNA turn- over through microRNAs in ESCs (Ling et al., 2011; Tritschler et al., 2009 ). The promoter-mediated mRNApruning function defined here may represent an important mechanism to ensure ESC maintenance. Interestingly, two recent studies in yeast have shown that promoters can dictate mRNA stability by recruiting proteins that target mRNAs for cytoplasmic degradation (Bregman et al., 2011; Trcek et al., 2011) . Although the proteins involved in the promoterbased marking of mRNAs are different in the yeast studies and in our study, our findings strongly suggest that the promoter-mediated control of mRNA stability is evolutionarily conserved.
Dcp1a, Edc3, and Dcp2 have been found in the same complex with TTF2 (a transcriptional terminator), and they have been implicated in facilitating mRNA decapping during transcription, which inhibits transcriptional elongation in both HeLa and HEK293 cells (Brannan et al., 2012) . Dcp1a has also been shown to bind to Smad4 to activate target genes upon TGF-b signaling in different somatic tissue culture cells (Bai et al., 2002) . However, unlike these previous reports, our studies show that the Utf1-mediated recruiting of Dcp1a to bivalent promoters in ESCs does not affect transcription, but it tags mRNA for posttranscriptional degradation in the cytoplasm.
The buffer function of Utf1 that we uncovered suggests that although removing Utf1 may not block lineage specification and differentiation, it would lead to inappropriate coupling of developmental processes and cell proliferation. Our preliminary analyses of Utf1 null mice are consistent with this prediction (data not shown). Utf1 is localized on the human chromosome 10q26.3, near the telomere. Humans bearing a heterozygous deletion of 10q26.3 exhibit a number of developmental abnormalities and retarded growth (Kehrer-Sawatzki et al., 2005) . Our findings suggest that Utf1 heterozygosity could be responsible for some of the abnormalities in the 10q26.3 patients.
EXPERIMENTAL PROCEDURES Karyotype Analyses of ESCs and Differentiation Assays
These procedures were performed as described previously (Creyghton et al., 2008; Kim et al., 2011; Niwa et al., 2000; Vong et al., 2010) and in the Extended Experimental Procedures.
Utf1 Pull-Down, Western Blotting, and MS V6.5 ESCs (1-2 3 10 9 ) were used to make nuclear extracts. After dialyzing the extract into a low-salt buffer, a Utf1 polyclonal antibody was used to immunoprecipitate Utf1 and its associated proteins. ESCs (1 3 10 7 ) expressing either BirA alone or both BirA and biotin-Utf1 were used for streptavidin pull-down of biotin-Utf1. See the Extended Experimental Procedures for more details. RNAi-Mediated Gene Silencing in ESCs shRNAs were purchased from Open Biosystems to knock down the mRNA of Arf (TRCN0000077816), Utf1 (TRCN0000081708), Jarid2 (TRCN0000096642), and Dcp1a (shRNA-1:TRCN0000096664, shRNA-2:TRCN0000096665). See the Extended Experimental Procedures for more details.
Cell Proliferation Assay
ChIP Assays
The ChIP-qPCR and ChIP-seq assays were performed according to the conditions suggested by the manufacturers of ChIP-grade antibodies to H3K27me3 (Abcam, ab6002), H3K4me3 (Cell Signaling, 9751), Suz12 (Cell Signaling, 3737), and Dcp1a (WH0055802) with modifications (Jia et al., 2007) . Biotin-ChIP was performed as previously described . See the Extended Experimental Procedures for detailed procedures, data analyses, and primer information.
Sequential ChIP Assay
Sample treatment and immunoprecipitations were performed using standard ChIP assay procedures. After the first immunoprecipitation, chromatin was eluted in a solution of 30 mM DTT, 500 mM NaCl, and 0.1% SDS at 37 C as described (Bernstein et al., 2006) . Eluted chromatin was diluted 50-fold and subjected to biotin-Utf1-ChIP as described in the Extended Experimental Procedures.
Whole-Transcriptome Shotgun Sequencing (RNA-Seq) Total RNA was isolated from 10 7 ESCs with the RNeasy Plus kit (QIAGEN). The poly(A)-containing mRNAs were purified, and libraries were built following Illumina TruSeq RNA protocols. Libraries were sequenced using an Illumina HiSeq 2000. 100 bp-long reads from both ends were obtained. See the Extended Experimental Procedures for more details.
Cell-Cycle Analyses
ESCs were trypsinized and resuspended in 0.5 ml PBS followed by the addition of 0.5 ml of 100% ice-cold ethanol in a drop-wise manner while vortexing.
After incubation for 20 min on ice, cells were harvested and washed by PBS containing 1% FBS. Next, cells were incubated in PBS with 25 mg/ml RNase A at 37 C for 30 min to digest RNA. Finally, cells were stained by 50 mg/ml propidium iodide for 10 min at room temperature and analyzed by flow-cytometry using BD-FACS Calibur.
Determining mRNA Degradation Profile ESCs were cultured as described above. Cells were treated with 1 mM flavopiridol (Sigma cat #F3055) and harvested at different time points. mRNA extraction and northern blotting analyses are described in the Extended Experimental Procedures.
Nuclear Run-on and S1 Nuclease Protection Assays ESCs were cultured as described above. Cells were treated with 50 mM c-Myc inhibitor 10058-F4 (Sigma cat #F3680) and harvested after 9 hr. Whole ESC and nuclear extract were harvested as described above. S1 nuclease protection assay was performed as previously described (Mendrysa and Perry, 2000) . For details, see the Extended Experimental Procedures.
EMSA
A 74 bp mouse genomic sequence containing the predicted Utf1-and Jarid2-binding motifs was labeled by g-32 P-ATP and incubated with ESC nuclear extract. The unlabeled competitor probe was used at 100-fold excess to the labeled probe. Super-shift was performed by incubating the reactions with antibodies against Utf1 or Suz12. For details, see the Extended Experimental Procedures.
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All ChIP-seq and RNA-seq data sets have been deposited into the GEO repository (GSE39513).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four figures, and seven tables and can be found with this article online at http://dx.doi.org/10.1016/j.cell.2012.09.023.
